Evaluating the Utility of the C-Reactive Protein to Albumin Ratio in Retinal Vein Occlusion Assessment
By
Esra Vural
Leyla Hazar
November 25, 2025
Clinical Scorecard: Evaluating the Utility of the C-Reactive Protein to Albumin Ratio in Retinal Vein Occlusion Assessment
At a Glance
Category Detail
Condition Retinal Vein Occlusion (RVO) Key Mechanisms Intraluminal thrombi, endothelial damage, systemic inflammation, hypercoagulation. Target Population Patients diagnosed with RVO, including those with branch and central RVO. Care Setting Ophthalmology outpatient clinic.
Key Highlights
RVO prevalence rates: 4.42 per 1000 for branch RVO, 0.80 for central RVO. CRP/albumin ratio is a significant prognostic indicator for RVO. Study included 34 RVO patients and 34 matched controls. Mean age of RVO patients: 58.73 years. Cut-off value for CRP/albumin ratio in RVO: 0.42 with 79% sensitivity. Guideline-Based Recommendations
Diagnosis
RVO diagnosed via fundus examination, fluorescein angiography, and SD-OCT. Management
Consultation with cardiology and internal medicine to identify risk factors. Monitoring & Follow-up
Regular assessment of CRP/albumin ratio and other inflammatory markers. Risks
Risk factors include cardiovascular diseases, diabetes, smoking, hypertension, and atherosclerosis. Patient & Prescribing Data
Patients with RVO, excluding those with systemic diseases or on specific medications.
Focus on managing underlying risk factors and monitoring inflammatory markers.
Clinical Best Practices
Evaluate CRP/albumin ratio alongside other inflammatory markers. Conduct comprehensive risk factor assessment in RVO patients. Utilize SD-OCT for detailed ocular assessment. References
